ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding ProQR Therapeutics N.V. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 74 | 58 | −16 |
| Shares | 45.4M | 31.7M | −13.7M (−30.1%) |
| Value | $364.8M | $28.7M | −$336.0M (−92.1%) |
New holders (17)
Institutions that held ProQR Therapeutics N.V. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| M28 Capital Management LP | 1,001,800 | $907.0K | 0.83% |
| Two Sigma Investments, LP | 744,377 | $674.0K | 0.00% |
| Renaissance Technologies LLC | 604,181 | $547.0K | 0.00% |
| XTX Topco Ltd | 210,587 | $191.0K | 0.08% |
| Two Sigma Advisers, LP | 131,700 | $119.0K | 0.00% |
| LMR Partners LLP | 109,824 | $99.0K | 0.00% |
| Monaco Asset Management SAM | 90,900 | $82.0K | 0.04% |
| Caption Management, LLC | 60,000 | $55.0K | 0.00% |
| Squarepoint Ops LLC | 49,878 | $45.0K | 0.00% |
| Atom Investors LP | 30,422 | $28.0K | 0.01% |
| Two Sigma Securities, LLC | 13,941 | $13.0K | 0.00% |
| Bayesian Capital Management, LP | 13,600 | $12.0K | 0.00% |
| Jefferies Group LLC | 11,375 | $10.3K | 0.00% |
| Algert Global LLC | 11,310 | $10.0K | 0.00% |
| JustInvest LLC | 11,312 | $10.0K | 0.00% |
| Acadian Asset Management LLC | 8,925 | $8.00K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,819 | $3.00K | 0.00% |
Sold out (33)
Institutions that held ProQR Therapeutics N.V. at the end of Q4 2021 and filed for Q1 2022 without it.